NMR-based metabolomics and breath studies show lipid and protein catabolism during low dose chronic T(1)AM treatment. - Wikidata - awgldk - TriplyDB

NMR-based metabolomics and breath studies show lipid and protein catabolism during low dose chronic T(1)AM treatment.

NMR-based metabolomics and breath studies show lipid and protein catabolism during low dose chronic T(1)AM treatment.

http://www.wikidata.org/entity/Q36955148

about

Inverse agonistic action of 3-iodothyronamine at the human trace amine-associated receptor 5 Modulation of gene expression by 3-iodothyronamine: genetic evidence for a lipolytic pattern Torpor: The Rise and Fall of 3-Monoiodothyronamine from Brain to Gut-From Gut to Brain?Urine Metabolomics by (1)H-NMR Spectroscopy Indicates Associations between Serum 3,5-T2 Concentrations and Intermediary Metabolism in Euthyroid Humans Diabetes and the metabolic syndrome: possibilities of a new breath test in a dolphin model.Metabolic profiling reveals reprogramming of lipid metabolic pathways in treatment of polycystic ovary syndrome with 3-iodothyronamine Uptake of 3-iodothyronamine hormone analogs inhibits the growth and viability of cancer cells.Update on 3-iodothyronamine and its neurological and metabolic actions.Metabolic Reprogramming by 3-Iodothyronamine (T1AM): A New Perspective to Reverse Obesity through Co-Regulation of Sirtuin 4 and 6 Expression.

P2860

Q28257584-E6E6F298-D6F8-4CA5-B7A5-FD611400F0EB Q28544799-4F7F1AD1-A007-4C9B-A7DD-BA19419EE978 Q33742405-F5F610ED-8D6B-4479-A0BB-970065313AF9 Q36267320-EEB082A1-C6B5-4E0A-9BE6-B01078CEA9A4 Q37339115-1E2B847F-8188-40AD-9CA9-FB244D45156B Q37599600-50CFC4AB-D1DC-4852-BE1D-A1B5A6A0DB44 Q37734776-5370370D-5343-44A3-BF5F-78C72CACEC9B Q38264120-CA5BD4FA-4EB5-4B92-83A5-BF14B029E9AF Q54108127-88A837E1-3C58-4ECF-83B3-1867081D3B99

P2860

NMR-based metabolomics and breath studies show lipid and protein catabolism during low dose chronic T(1)AM treatment.

http://www.wikidata.org/entity/Q36955148

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

NMR-based metabolomics and bre ...... dose chronic T(1)AM treatment.

@en

type

label

NMR-based metabolomics and bre ...... dose chronic T(1)AM treatment.

@en

prefLabel

NMR-based metabolomics and bre ...... dose chronic T(1)AM treatment.

@en

P1433

Q36955148-5C42F86B-DC92-419C-8224-2868DE56CAD3

P1476

Q36955148-945ECA59-799E-4EC8-958A-DA52FACEB06F

P2093

Q36955148-12D5BFC8-71C4-424A-835F-5C104C071649

Q36955148-468D8209-11AD-42D6-8CCC-F97F21E72114

Q36955148-6C8C150A-D2C2-4F4A-8F2A-175CF4AFE69B

Q36955148-86BD15BD-5D49-4E9A-B1AD-2D391523332C

Q36955148-8AF668E3-C8D5-499C-B404-011DE627561D

Q36955148-9D5EB9C6-DE1C-40BF-8784-24796FB2BE01

Q36955148-C4B2825A-EFA2-45C1-8F55-97D7D79DF267

Q36955148-E33DBCCA-9CBD-4EA6-B6E9-FA893D8F5134

P2860

Q36955148-21F54D09-620F-44FB-AC6D-298AFBD38A84

Q36955148-2773A91C-55C9-40DD-8721-00D4E133E9EF

Q36955148-330A8F1C-B604-4C07-ACA7-C3231769FBCE

Q36955148-3ECD3797-D056-45CA-9D81-33170AA04CE1

Q36955148-544E5506-347B-4726-BED6-D55BB24035BD

Q36955148-5B63A40F-5F72-46C2-8B47-D2FD626E5654

Q36955148-7D364094-D12D-4253-A80B-F7C272A770B9

Q36955148-87643FE1-DCD3-42CD-8634-F6C2460BE155

Q36955148-8AF20FBC-9454-4CAB-9C55-9B03A8B705D2

Q36955148-9354C549-1882-4B16-B13A-B71E7C74AC62

P304

Q36955148-52E09405-BD35-497A-841B-047674DE046E

P31

Q36955148-9B759AFE-88C3-48AC-8942-F173BBCAA97F

P356

Q36955148-2EEEB6BB-C2B9-4AEB-BC61-CCC7313545A2

P433

Q36955148-903E1214-79CB-4FCB-B760-019C158A6919

P478

Q36955148-D4F2F0C1-18B3-49F0-811F-CD2A9967820A

P50

Q36955148-3EC6DBEF-6F79-4BE0-89A7-9F59D041D93C

P577

Q36955148-10FD61A4-AD9B-4E14-9017-B6C19604B6B9

P5875

Q36955148-BC3B96FA-7F18-4D28-8F72-A9C9570D0C29

P698

Q36955148-BC730FCF-7E1A-495A-99AC-D4A6D9A1984C

P921

Q36955148-3DF5592D-68B5-4C41-AB53-6D515299C451

P932

Q36955148-67A376E9-5B48-430A-A160-6350231567A4

P356

P1433

P1476

NMR-based metabolomics and bre ...... dose chronic T(1)AM treatment

@en

P2093

D E Butz

http://www.w3.org/2001/XMLSchema#string

F M Assadi-Porter

http://www.w3.org/2001/XMLSchema#string

G Chiellini

http://www.w3.org/2001/XMLSchema#string

H Reiland

http://www.w3.org/2001/XMLSchema#string

J A Haviland

http://www.w3.org/2001/XMLSchema#string

M Tonelli

http://www.w3.org/2001/XMLSchema#string

T S Scanlan

http://www.w3.org/2001/XMLSchema#string

W P Porter

http://www.w3.org/2001/XMLSchema#string

P2860

Trace amine-associated receptors and their ligands

3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone

Cardiac effects of 3-iodothyronamine: a new aminergic system modulating cardiac function

Novel diagnostics of metabolic dysfunction detected in breath and plasma by selective isotope-assisted labeling

Probing cell type-specific functions of Gi in vivo identifies GPCR regulators of insulin secretion.

3-Iodothyronamine: a modulator of the hypothalamus-pancreas-thyroid axes in mice.

Minireview: 3-Iodothyronamine (T1AM): a new player on the thyroid endocrine team?

3-Iodothyronamine (T(1)AM): a new chapter of thyroid hormone endocrinology?

Nongenomic signaling pathways triggered by thyroid hormones and their metabolite 3-iodothyronamine on the cardiovascular system.

Transport of thyroid hormones is selectively inhibited by 3-iodothyronamine.

P304

2538-2544

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/OBY.20391

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P50

Riccardo Zucchi

P577

2013-05-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236065122

http://www.w3.org/2001/XMLSchema#string

P698

23512955

http://www.w3.org/2001/XMLSchema#string

P921

P932

3692609

http://www.w3.org/2001/XMLSchema#string